Trial Profile

Tiratricol Treatment of Children with Monocarboxylate Transporter 8 Deficiency: Triac Trial II

Status: Active, no longer recruiting

Phase of Trial: Phase II/III

Latest Information Update: 05 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tiratricol (Primary)
Indications Allan-Herndon-Dudley syndrome
Focus Registrational; Therapeutic Use
Acronyms Triac Trial II
Sponsors Rare Thyroid Therapeutics

Most Recent Events

20 Feb 2026 Planned End Date changed from 1 Jun 2026 to 18 Aug 2027.
20 Feb 2026 Planned primary completion date changed from 1 Jun 2024 to 18 Jul 2027.
13 Feb 2025 The EU approval is applicable to all 27 European Union member states, as well as Iceland, Norway, and Liechtenstein.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com